Investor Alert: Holzer Holzer & Fistel, LLC Announces Investigation Into Biolase, Inc

Holzer Holzer & Fistel, LLC is investigating whether Biolase, Inc. (“Biolase” or the “Company”) (NASDAQ: BIOL) and/or certain of its officers complied with the federal securities laws when making statements to investors. Specifically, the investigation focuses on statements issued by Biolase regarding the Company’s ability to transition to a direct sales model and to fund its operations.

If you purchased Biolase common stock between January 7, 2013 and August 13, 2013 and suffered losses on that investment, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832 regarding your legal rights.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Copyright Business Wire 2010

If you liked this article you might like

Insider Trading Alert - NHC, BIOL And ASGN Traded By Insiders

Insider Trading Alert - NHC, BIOL And ASGN Traded By Insiders

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

Why Biolase (BIOL) Stock Is Higher Today

Why Biolase (BIOL) Stock Is Higher Today

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now